D
Debora B. Perucello
Researcher at University of São Paulo
Publications - 2
Citations - 576
Debora B. Perucello is an academic researcher from University of São Paulo. The author has contributed to research in topics: Inflammasome. The author has an hindex of 2, co-authored 2 publications receiving 189 citations.
Papers
More filters
Journal ArticleDOI
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
Tamara S Rodrigues,Keyla Santos Guedes de Sá,Adriene Y. Ishimoto,Amanda Becerra,Samuel L. Oliveira,Letícia Yamawaka de Almeida,Augusto V. Gonçalves,Debora B. Perucello,Warrison A. Andrade,Ricardo M. C. Castro,Flávio P. Veras,Juliana E Toller-Kawahisa,Daniele C. Nascimento,Mikhael Haruo Fernandes de Lima,Camila Meirelles de Souza Silva,Diego B. Caetite,Ronaldo B. Martins,Italo A. Castro,Marjorie Cornejo Pontelli,Fábio Cury de Barros,Fábio Cury de Barros,Natalia B. do Amaral,Marcela C Giannini,Letícia Pastorelli Bonjorno,Maria Isabel Fernandes Lopes,Rodrigo de Carvalho Santana,Fernando Crivelenti Vilar,Maria Auxiliadora-Martins,Rodrigo Luppino-Assad,Sérgio C. L. Almeida,Fabiola Reis de Oliveira,Sabrina Setembre Batah,Li Siyuan,Maira N. Benatti,Thiago M. Cunha,José C. Alves-Filho,Fernando Q. Cunha,Larissa D. Cunha,Fabiani Gai Frantz,Tiana Kohlsdorf,Alexandre Todorovic Fabro,Eurico Arruda,Renê Donizeti Ribeiro de Oliveira,Paulo Louzada-Junior,Dario S. Zamboni +44 more
TL;DR: This work shows that inflammasomes are activated in response to SARS-CoV-2 infection in vitro and in COVID-19 patients, contributing to the exacerbated inflammatory response, impacting disease progression and clinical outcome.
Posted ContentDOI
Inflammasome activation in COVID-19 patients
Tamara S Rodrigues,Keyla Sg Sa,Adriene Y. Ishimoto,Amanda Becerra,Samuel L. Oliveira,Letícia Yamawaka de Almeida,Augusto V. Gonçalves,Debora B. Perucello,Warrison A. Andrade,Ricardo M. C. Castro,Flávio P. Veras,Juliana E Toller-Kawahisa,Daniele C. Nascimento,Mikhael Hf de Lima,Camila A. M. Silva,Diego B. Caetite,Ronaldo B. Martins,Italo A. Castro,Marjorie Cornejo Pontelli,Fábio Cury de Barros,Fábio Cury de Barros,Natalia B. do Amaral,Marcela C Giannini,Letícia Pastorelli Bonjorno,Maria Isabel Fernandes Lopes,Maira N. Benatti,Rodrigo de Carvalho Santana,Fernando Crivelenti Vilar,Maria Auxiliadora-Martins,Rodrigo Luppino-Assad,Sergio Cl Almeida,Fabiola Reis de Oliveira,Sabrina Setembre Batah,Li Siyuan,Thiago M. Cunha,José C. Alves-Filho,Fernando Q. Cunha,Larissa D. Cunha,Fabiani Gai Frantz,Tiana Kohlsdorf,Alexandre Todorovic Fabro,Eurico Arruda,Rene Dr de Oliveira,Paulo Louzada-Junior,Dario S. Zamboni +44 more
TL;DR: It is demonstrated that the NLRP3 inflammasome is activated in response to SARS-CoV-2 infection and it is active in COVID-19, influencing the clinical outcome of the disease.